Covered recipient · General Payments record
MELODIE J MOPE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,871.46
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $701.98 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $170.06 | 10 |
| Medtronic, Inc. | $158.07 | 1 |
| Novo Nordisk AS | $80.68 | 5 |
| Acerta Pharma LLC | $59.21 | 4 |
| Lilly USA, LLC | $56.42 | 3 |
| Amgen Inc. | $53.26 | 3 |
| Exact Sciences Corporation | $48.07 | 2 |
| ABBVIE INC. | $46.14 | 3 |
| Currax Pharmaceuticals LLC | $15.07 | 1 |
| Kowa Pharmaceuticals America, Inc. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.17 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105062056 | CMS |
| ABBVIE INC. | $19.11 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105062058 | CMS |
| ABBVIE INC. | $13.86 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105062060 | CMS |
| Amgen Inc. | $17.83 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115943361 | CMS |
| Amgen Inc. | $16.43 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115943368 | CMS |
| Amgen Inc. | $19.00 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115943372 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.76 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104596314 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.71 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104776070 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.53 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104651245 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.21 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105577276 | CMS |
| Currax Pharmaceuticals LLC | $15.07 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089513384 | CMS |
| Exact Sciences Corporation | $20.74 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114795924 | CMS |
| Exact Sciences Corporation | $27.33 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114795930 | CMS |
| Kowa Pharmaceuticals America, Inc. | $15.00 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113468739 | CMS |
| Lilly USA, LLC | $15.22 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135189201 | CMS |
| Lilly USA, LLC | $20.22 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135171448 | CMS |
| Lilly USA, LLC | $20.98 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135183287 | CMS |
| Medtronic, Inc. | $158.07 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119521046 | CMS |
| Novo Nordisk Inc | $15.78 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930128 | CMS |
| Novo Nordisk Inc | $13.40 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096872409 | CMS |
| Novo Nordisk Inc | $16.99 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097250385 | CMS |
| Novo Nordisk Inc | $18.66 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097001390 | CMS |
| Novo Nordisk Inc | $15.85 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096783598 | CMS |
| PFIZER INC. | $5.68 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033943 | CMS |
| PFIZER INC. | $15.23 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131137403 | CMS |
| PFIZER INC. | $2.32 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033539 | CMS |
| PFIZER INC. | $18.62 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131235736 | CMS |
| PFIZER INC. | $19.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132033945 | CMS |
| PFIZER INC. | $17.11 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131381867 | CMS |
| PFIZER INC. | $18.78 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131375156 | CMS |
| PFIZER INC. | $26.45 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131979125 | CMS |
| PFIZER INC. | $21.83 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131957151 | CMS |
| PFIZER INC. | $24.58 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132113603 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.